Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.
Clinical trial NCT05155566 · COMPLETED
Trial details
- NCT number
- NCT05155566
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-05-15
- Primary completion
- 2021-03-12
- Enrollment
- 847
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.